Matthew Lumley
Amministratore Delegato presso Myosana Therapeutics, Inc.
Profilo
Matthew Lumley is currently the Chief Executive Officer at Myosana Therapeutics, Inc. and a Venture Partner at Medicxi Ventures (Jersey) Ltd.
He completed his undergraduate degree at Imperial College London in 2007 and his doctorate degree at King's College London in 2015.
Posizioni attive di Matthew Lumley
| Società | Posizione | Inizio |
|---|---|---|
Medicxi Ventures (Jersey) Ltd.
 Medicxi Ventures (Jersey) Ltd. Investment ManagersFinance Medicxi Ventures (Jersey) Ltd. (Medicxi) is an independent venture capital firm founded in 2016 by Francesco de Rubertis, Michèle Ollier, and Kevin S. Johnson. The firm is headquartered in London. | Investitore di Private Equity | 01/01/2023 |
Myosana Therapeutics, Inc.
 Myosana Therapeutics, Inc. BiotechnologyHealth Technology Myosana Therapeutics, Inc. is a biotech company develops novel platform technology. The company was founded by Stan Froehner, Nick Whitehead and Steve Runnels and is headquartered in Seattle, WA. | Amministratore Delegato | 01/11/2021 |
Formazione di Matthew Lumley
| Imperial College London | Undergraduate Degree |
| King's College London | Doctorate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 2 |
|---|---|
Medicxi Ventures (Jersey) Ltd.
Medicxi Ventures (Jersey) Ltd. Investment ManagersFinance Medicxi Ventures (Jersey) Ltd. (Medicxi) is an independent venture capital firm founded in 2016 by Francesco de Rubertis, Michèle Ollier, and Kevin S. Johnson. The firm is headquartered in London. | Finance |
Myosana Therapeutics, Inc.
Myosana Therapeutics, Inc. BiotechnologyHealth Technology Myosana Therapeutics, Inc. is a biotech company develops novel platform technology. The company was founded by Stan Froehner, Nick Whitehead and Steve Runnels and is headquartered in Seattle, WA. | Health Technology |
- Borsa valori
- Insiders
- Matthew Lumley
